Platelet-rich plasma pretreatment protects anterior cruciate ligament fibroblasts correlated with PI3K-Akt-mTOR pathway under hypoxia condition

BACKGROUND: /Objective: Biological factors such as platelet-rich plasma (PRP) combined with anterior cruciate ligament (ACL) primary repair technology are used to treat ACL injury. However, the protective mechanism of PRP for ACL fibroblasts under hypoxia condition is still unknown. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yanwei, Li, Yue, Fu, Sai Chuen, Shen, Jiewei, Zhang, Hui, Jiang, Chunyan, Shu-Hang Yung, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283994/
https://www.ncbi.nlm.nih.gov/pubmed/35891713
http://dx.doi.org/10.1016/j.jot.2022.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283994/
https://www.ncbi.nlm.nih.gov/pubmed/35891713
http://dx.doi.org/10.1016/j.jot.2022.02.002

Ejemplares similares